Genetic variation of the human α-2-heremans-schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Zhu, Xiaohui ^a   Wang, Yan ^a,e   Zhang, Hongxing ^b,f   Liu, Xuan ^a   Chen, Ting ^a   Yang, Ruifu ^c   Shi, Yuling ^d   Cao, Wuchun ^c   Li, Ping ^a   Ma, Qingjun ^a   Zhai, Yun ^b,f   He, Fuchu ^b,f   Zhou, Gangqiao ^b,f   Cao, Cheng ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f National Engineering Research Center for Protein Drugs   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 HEREMANS SCHMID GLYCOPROTEIN; CYTOCHROME P450 3A; GLYCOPROTEIN; UNCLASSIFIED DRUG; AHSG PROTEIN, HUMAN; FETUIN A;

ADULT; AGE DISTRIBUTION; AHSG GENE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYP4F3 GENE; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTERACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; BLOOD; CELL LINE; CELL STRAIN HEPG2; GENETICS; METABOLISM; PATHOGENICITY; PROMOTER REGION; VIROLOGY;

SARS CORONAVIRUS;

ADOLESCENT; ADULT; ALPHA-2-HS-GLYCOPROTEIN; CELL LINE; FEMALE; GENETIC VARIATION; GENOTYPE; HEP G2 CELLS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; YOUNG ADULT;

EID: 80051718944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023730     Document Type: Article

References (41)

1. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, et al. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319-1325.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348: 1953-1966.
3. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967-1976.
4. Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, et al. (2004) Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363: 841-845.
5. Chang WT, Kao CL, Chung MY, Chen SC, Lin SJ, et al. (2004) SARS exposure and emergency department workers. Emerg Infect Dis 10: 1117-1119.
6. Li G, Zhao Z, Chen L, Zhou Y, (2003) Mild severe acute respiratory syndrome. Emerg Infect Dis 9: 1182-1183.
7. Ho KY, Singh KS, Habib AG, Ong BK, Lim TK, et al. (2004) Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 189: 642-647.
8. Wilder-Smith A, Teleman MD, Heng BH, Earnest A, Ling AE, et al. (2005) Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis 11: 1142-1145.
9. Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, et al. (2005) Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 192: 1355-1361.
10. Ip WK, Chan KH, Law HK, Tso GH, Kong EK, et al. (2005) Mannose-bingding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 191: 1697-1704.
11. Ng MW, Zhou G, Chong WP, Lee LW, Law HK, et al. (2007) The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis 7: 50.
12. Chong WP, Ip WK, Tso GH, Ng MW, Wong WH, et al. (2006) The interferon gama gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis 6: 82.
13. He J, Feng D, de Vlas SJ, Wang H, Fontanet A, et al. (2006) Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis 6: 106.
14. Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, et al. (2003) Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet 4: 9.
15. Ng MH, Lau KM, Li L, Cheng SH, Chan WY, et al. (2004) Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 190: 515-518.
16. Xiong P, Zeng X, Song MS, Jia SW, Zhong MH, et al. (2008) Lack of association between HLA-A,-B and-DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. Int J Immunogenet 35: 69-74.
17. Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, et al. (2006) Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 38: 38-46.
18. Zhi L, Zhou G, Zhang H, Zhai Y, Yang H, et al. (2007) Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection. Nat Genet 39: 692-694; author reply 694-696.
19. Tang NL, Chan PK, Hui DS, To KF, Zhang W, et al. (2007) Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection. Nat Genet 39: 691-692; author reply 694-696.
20. Che XY, Hao W, Wang Y, Di B, Yin K, et al. (2004) Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis 10: 1947-1949.
21. Yasui F, Kai C, Kitabatake M, Inoue S, Yoneda M, et al. (2008) Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV. J Immunol 181: 6337-6348.
22. Zhao J, Huang Q, Wang W, Zhang Y, Lv P, et al. (2007) Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 81: 6079-6088.
23. Zhu MS, Pan Y, Chen HQ, Shen Y, Wang XC, et al. (2004) Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 92: 237-243.
24. Zhou B, Liu J, Wang Q, Liu X, Li X, et al. (2008) The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha. J Virol 82: 6962-6971.
25. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, et al. (1979) Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64: 1118-1129.
26. Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, et al. (2001) Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15: 181-185.
27. Li W, Zhu S, Li J, Huang Y, Zhou R, et al. (2011) A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One 6: e16945.
28. Murphy RC, Gijon MA, (2007) Biosynthesis and metabolism of leukotrienes. Biochem J 405: 379-395.
29. Kannan S, (2002) Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation. Med Hypotheses 59: 261-265.
30. Liu X, Shi Y, Li P, Li L, Yi Y, et al. (2004) Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol 11: 227-228.
31. Shi Y, Yi Y, Li P, Kuang T, Li L, et al. (2003) Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol 41: 5781-5782.
32. Osawa M, Umetsu K, Ohki T, Nagasawa T, Suzuki T, et al. (1997) Molecular evidence for human alpha 2-HS glycoprotein (AHSG) polymorphism. Human Genetics 99: 18-21.
33. Osawa M, Tian W, Horiuchi H, Kaneko M, Umetsu K, (2005) Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels. Human Genetics 116: 146-151.
34. Inoue M, Takata H, Ikeda Y, Suehiro T, Inada S, et al. (2008) A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity. Diabetes Res Clin Pract 79: 164-170.
35. Bushel P, Kim JH, Chang W, Catino JJ, Ruley HE, et al. (1995) Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. Oncogene 10: 1361-1370.
36. Schreiber M, Kolbus A, Piu F, Szabowski A, Möhle-Steinlein U, et al. (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes & development 13: 607.
37. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, et al. (1998) Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci U S A 95: 14429-14434.
38. Kalabay L, Cseh K, Benedek S, Fekete S, Masszi T, et al. (1991) Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study. Ann Hematol 63: 264-269.
39. Sato H, Kazama JJ, Wada Y, Kuroda T, Narita I, et al. (2007) Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis. Intern Med 46: 1685-1691.
40. Jezequel M, Seta N, Corbic M, Feger J, Durand G, (1988) Modifications of concanavalin A patterns of A1-acid-glyco-protein and α2-HS-glycoprotein in alcoholic liver disease. Clin Chim Acta 176: 49-58.
41. Kalabay L, Cseh K, Pozsonyi T, Jakab L, Jakab L, et al. (1992) Diagnostic value of the determination of serum α2-HS-glycoprotein concentration. Orv Hetil 133: 1553.